3.1172
前日終値:
$3.27
開ける:
$3.26
24時間の取引高:
37,045
Relative Volume:
0.34
時価総額:
$40.05M
収益:
-
当期純損益:
$-70.20M
株価収益率:
-0.0695
EPS:
-44.82
ネットキャッシュフロー:
$-50.66M
1週間 パフォーマンス:
-6.39%
1か月 パフォーマンス:
+15.03%
6か月 パフォーマンス:
+24.69%
1年 パフォーマンス:
-80.90%
Onkure Therapeutics Inc Stock (OKUR) Company Profile
名前
Onkure Therapeutics Inc
セクター
電話
(720) 307-2892
住所
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
OKUR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OKUR
Onkure Therapeutics Inc
|
3.1186 | 44.24M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.81 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.88 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.01 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.66 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.94 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-30 | 開始されました | Evercore ISI | Outperform |
| 2024-12-05 | 開始されました | Leerink Partners | Outperform |
| 2024-10-10 | 開始されました | Oppenheimer | Outperform |
| 2023-12-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | ダウングレード | Jefferies | Buy → Hold |
| 2023-12-15 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-12-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | 開始されました | William Blair | Outperform |
| 2023-08-28 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-03 | 開始されました | BofA Securities | Buy |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-01-27 | 開始されました | Robert W. Baird | Outperform |
| 2021-12-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-22 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-05-04 | 開始されました | Jefferies | Buy |
| 2021-05-04 | 開始されました | Piper Sandler | Overweight |
| 2021-05-04 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Onkure Therapeutics Inc (OKUR) 最新ニュース
How to read the order book for OnKure Therapeutics Inc.Portfolio Value Summary & Growth Oriented Trade Recommendations - newser.com
Custom watchlist performance reports with OnKure Therapeutics Inc.2025 Year in Review & Long-Term Capital Growth Ideas - newser.com
Will OnKure Therapeutics Inc. stock remain a Wall Street favoriteWeekly Market Outlook & Accurate Entry/Exit Alerts - newser.com
Institutional scanner results for OnKure Therapeutics Inc.2025 Risk Factors & Daily Profit Maximizing Tips - newser.com
How OnKure Therapeutics Inc. stock reacts to inflationary pressuresProfit Target & Risk Managed Investment Strategies - newser.com
Onkure Therapeutics Inc expected to post a loss of $1.20 a shareEarnings Preview - TradingView
Is it time to cut losses on OnKure Therapeutics Inc.Portfolio Update Summary & Daily Stock Trend Watchlist - newser.com
OnKure Therapeutics Inc.’s volatility index tracking explainedGold Moves & Short-Term Trading Alerts - newser.com
What valuation multiples suggest for OnKure Therapeutics Inc. stockWeekly Market Outlook & Expert Curated Trade Setups - newser.com
Will OnKure Therapeutics Inc. stock continue upward momentumWeekly Loss Report & Free Growth Oriented Trading Recommendations - newser.com
What momentum shifts mean for OnKure Therapeutics Inc.Earnings Recap Summary & Growth-Oriented Investment Plans - newser.com
Analyzing drawdowns of OnKure Therapeutics Inc. with statistical toolsIPO Watch & Target Return Focused Stock Picks - newser.com
Is OnKure Therapeutics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Expert Approved Momentum Ideas - newser.com
OnKure Therapeutics, Inc. (NASDAQ:OKUR) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
How rising interest rates impact OnKure Therapeutics Inc. stockJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Can you recover from losses in OnKure Therapeutics Inc.2025 Pullback Review & Risk Controlled Daily Plans - newser.com
How OnKure Therapeutics Inc. stock compares to market leadersWeekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Is OnKure Therapeutics Inc. stock affected by interest rate hikesExit Point & Safe Entry Zone Identification - fcp.pa.gov.br
Will OnKure Therapeutics Inc. stock continue dividend increases2025 Growth vs Value & Detailed Earnings Play Strategies - fcp.pa.gov.br
Can OnKure Therapeutics Inc. stock maintain growth trajectory2025 Dividend Review & Daily Oversold Bounce Ideas - fcp.pa.gov.br
How strong is OnKure Therapeutics Inc. stock revenue growth2025 Earnings Impact & Proven Capital Preservation Tips - fcp.pa.gov.br
Why hedge funds are buying OnKure Therapeutics Inc. stockJuly 2025 Price Swings & Comprehensive Market Scan Reports - fcp.pa.gov.br
What Analyst Models Predict for Ravinder Heights Limiteds 5Year GrowthValue Traps to Avoid & Big Gains Low Budget - earlytimes.in
Onkure Therapeutics Inc (OKUR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):